It has been demonstrated that lipid peroxidation, mediated by fatty acid transporter protein 2 (FATP2), supports the potent immunosuppressive effects of PMN-MDSCs in the TME, thereby promoting MDSC survival and inducing tumor progression in various mouse models [100]. The gene discussed is SLC27A2; the disease is neoplasm.